Aim Adverse drug events (ADEs) are harmful and unintended consequences of medications.
Their reporting is essential for drug safety monitoring and research, but it has not been …

Background: Adverse drug events are unintended and harmful events related to medications.
Adverse drug events are important for patient care, quality improvement, drug safety …

Objective Emergency department (ED)–initiated buprenorphine may prevent overdose.
Microdosing is a novel approach that does not require withdrawal, which can be a barrier to …

Objectives Adverse drug events (ADEs) cause or contribute to one in nine emergency
department (ED) presentations in North America and are often misdiagnosed. EDs have …

Background: Adverse drug events (ADEs) are unintended and harmful events related to
medication use. Up to 30% of serious ADEs recur within six months because culprit drugs are …

Background Adverse drug events (ADEs), harmful unintended consequences of medication
use, are a leading cause of hospital admissions, yet are rarely documented in a structured …

Background: To reduce medication discrepancies (unintended differences between a patient's
outpatient and inpatient medication regimens), Canadian institutions have implemented …

Background: Patients commonly transition between health care settings, requiring care
providers to transfer medication utilization information. Yet, information sharing about adverse …

Background Take-home buprenorphine/naloxone is an effective method of initiating opioid
agonist therapy in the Emergency Department (ED) that requires ED healthcare worker buy-…

Objectives Many emergency department (ED) patients with opioid use disorder are candidates
for home buprenorphine/naloxone initiation with to-go packs. We studied patient opinions …